Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Hologic Inc.

BioPhotonics
May 2009
Bedford, Mass.-based Hologic Inc. has received FDA approval for two of its tests for the human papilloma virus. The company’s HPV HR (high risk) and HPV 16/18 were designed to detect the 14 high-risk types of the virus, known to cause cervical cancer, and to detect types 16 and 18, which are associated with about 70 percent of cervical cancers, respectively.

BiophotonicsHologic Inc.News & Features

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.